CNDA Shopping Cart

Please leave this field blank.

Home My Account View Cart Checkout
CATEGORIES
NEWEST ITEM(S)
2022 Virtual Conference: The Holistic Human: Advances in Naturopathic Primary Care (self study)
BB11: Going Virtual: How offering online services could allow you to live your dream life (self study)
PW53: Therapeutic Considerations for COVID-19 (self study)
NW51: Intestinal Parasites – A New Approach to an Old Problem (self study)
PW52: Ketamine: Therapeutic History & Current Research (self study)
Email Excerpt Promo Add-on
Stand-Alone Email Promo Add-on
PW51 Current Research with MDMA (self study)
NW50: Chronic Fatigue Syndrome: Route to Resolution (self study)
PW50: Current Research with Psilocybin (self study)
RECENTLY VIEWED
PW53: Therapeutic Considerations for COVID-19 (self study)
PW53: Therapeutic Considerations for COVID-19 (self study) Storefront > Self-Study Pharmacy Webinars

View larger image
 
PW53: Therapeutic Considerations for COVID-19 (self study)
Price: $95.00
Status: Available
Quantity:

Please leave this field blank.

Pharmacy Webinar 53

CNDA Members: Use Your Coupon Code (member) At Checkout

Originally presented April 12, 2022

CMEs
2 pharmacy CEs 


Brenden Cochran, ND



This course will cover topics pertaining to the top therapeutics with the potential use of support of patients with COVID-19. This will include medications and natural methods. We will review safety, side effects, proposed pharmacological mechanisms and off label use. We will review the literature and clinical use of prophylaxis, current disease, and post covid support. FInally, we will cover the best current treatment considerations with approaching patients with COVID-19.

Goals and Objectives:

1. Understand the indications, pharmacology, safety, and side effects of pharmaceuticals being used to support patients with COVID-19.
2. Introduce nutraceuticals that have been shown to support those with COVID-19.
3. Review the literature of current medications and nutraceuticals for pre-covid support, during and post covid-19.
4. Review case studies where both pharmaceuticals and nutraceuticals were used in patient care.
5. Discuss best clinical outcomes with multiple therapeutic tools.